PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Greater Intermountain Node, a NIH NIDA Clinical Trial Network node and Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), University of Utah School of Medicine, Department of Internal Medicine, Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah, USA.\', \'Department of family medicine and emergency medicine, Université de Montréal, Montréal, Canada.\', \'Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah, USA.\', \'Vulnerable Veteran Innovative PACT (VIP) Initiative; Informatics, Decision-Enhancement, and Analytic Sciences Center (IDEAS Center), VA Salt Lake City Health Care System, Salt Lake City, Utah, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/08897077.2020.1787300
?:doi
?:hasPublicationType
?:journal
  • Substance abuse
is ?:pmid of
?:pmid
?:pmid
  • 32697171
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.009
?:rankingScore_hIndex
  • 36
is ?:relation_isRelatedTo_publication of
?:title
  • Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32697171>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32697171>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all